https://armypubs.army.mil/epubs/DR_pubs/DR_a/ARN44273-ARMY_DIR_2025-11-000-WEB-1.pdf
S E C R E T A R Y O F T H E A R M Y
W A S H I N G T O N
MEMORANDUM FOR SEE DISTRIBUTION
SUBJECT: Army Directive 2025-11 (Administrative Absence for Non-covered Assisted
Reproductive Technology)
1. References.
a. Department of Defense (DoD) Joint Travel Regulations (JTR), 4 February 2025
b. Performing the Duties of the Under Secretary of Defense (Personnel and Readiness)
memorandum (Non-covered Assisted Reproductive Technology), 3 February 2025, attachment 1
(Administrative Absence for Non-Covered Assisted Reproductive Technology)
c. DoD Instruction 1327.06 (Leave and Liberty Policy and Procedures), 16 June 2009,
incorporating Change 5, effective 25 August 2023
d. Army Directive 2023-05 (Administrative Absence for Non-covered Reproductive Health
Care), 27 February 2023 (hereby rescinded)
e. Army Regulation (AR) 40–66 (Medical Record Administration and Healthcare
Documentation), 17 June 2008, incorporating Rapid Action Revision, 4 January 2010
f. AR 600–8–10 (Leaves and Passes), 3 June 2020
2. Purpose. This directive rescinds Army Directive 2023-05 and implements DoD policy
changes for administrative absence associated with non-covered assisted reproductive
technology (ART).
3. Applicability. This policy applies to the Regular Army, Army National Guard/Army
National Guard of the United States, and U.S. Army Reserve.
4. Policy. For the definitions of terms used in this directive, see the enclosure. Where this
directive conflicts with any other Army policy or procedural guidance, this directive is
controlling. Effective immediately:
a. Commanders are responsible to meet operational requirements and protect the health and
safety of Soldiers in their care. Commanders will exercise objectivity, compassion, and
discretion when addressing all healthcare matters, including reproductive healthcare matters.
SUBJECT: Army Directive 2025-11 (Administrative Absence for Non-covered Assisted
Reproductive Technology)
b. Eligible Soldiers will be able to access lawfully available ART, as defined in the
enclosure to this directive, regardless of where they are stationed.
c. Eligible Soldiers may request an administrative absence from their normal duty station
without being charged leave to access non-covered ART. Requests must include supporting
documentation by a licensed medical provider validating the medical condition and location of
care.
d. Company-level, or equivalent, commanders may approve an administrative absence for a
period of up to 21 days per request for eligible Soldiers to receive or accompany a dependent or
dual-military spouse who receives non-covered ART.
e. The authority to disapprove a request for an administrative absence to receive or
accompany a dependent or dual-military spouse who receives non-covered ART is withheld to
brigade-level, or equivalent, commanders with a servicing legal advisor. The time from
submission of a valid request to approval or disapproval will not exceed 7 business days.
f. The period of absence will be limited to the minimum number of days essential to receive
the required care and travel needed to access the care by the most expeditious means of
transportation available.
g. This administrative absence may be granted regardless of whether such care is available
within the local area of the eligible Soldier’s duty location, as defined in reference 1a, or whether
the dependent or dual-military spouse resides with or is geographically separated from the
Soldier.
h. Requests for administrative absence will be given all due consideration and will be
granted to the greatest extent practicable, unless, in the judgment of the commander, the
Soldier’s absence would impair proper execution of the military mission.
i. Eligible Soldiers will not be granted an administrative absence if their intention is to sell,
to offer for sale, or to receive proceeds from a sale resulting from an ART procedure while on, or
in connection with taking, such absence.
j. In considering the mission impact of a Soldier’s request for an administrative absence for
ART care—for example, where recurring care may be necessary over a period of time—
commanders will coordinate with the eligible Soldier to balance operational requirements and the
healthcare schedule. Soldiers may need to disclose a minimum amount of health information
necessary for commanders to authorize the administrative absence.
2
Dan Driscoll
SUBJECT: Army Directive 2025-11 (Administrative Absence for Non-covered Assisted
Reproductive Technology)
k. Commanders may also grant a Soldier convalescent leave following receipt of non-
covered ART based on a recommendation of a DoD or civilian healthcare provider from whom
the Soldier is receiving care.
l. Consistent with existing law and Army policy, commanders will protect the privacy of
protected health information they receive under this policy. Such healthcare information will be
restricted to personnel with a specific need to know; that is, access to the information must be
necessary for the conduct of official duties. Personnel will also be accountable for safeguarding
this healthcare information consistent with existing law and reference 1e.
5. Proponent. The Assistant Secretary of the Army (Manpower and Reserve Affairs) is the
proponent for this policy. The Deputy Chief of Staff, G-1 will incorporate its provisions into
AR 600–8–10 within 2 years of the date of this directive.
6. Duration. This directive is rescinded on publication of the revised regulation.
Encl
DISTRIBUTION:
Principal Officials of Headquarters, Department of the Army
Commander
U.S. Army Forces Command
U.S. Army Training and Doctrine Command
U.S. Army Materiel Command
U.S. Army Futures Command
U.S. Army Pacific
U.S. Army Europe and Africa
U.S. Army Central
U.S. Army North
U.S. Army South
U.S. Army Special Operations Command
Military Surface Deployment and Distribution Command
U.S. Army Space and Missile Defense Command/Army Strategic Command
U.S. Army Cyber Command
U.S. Army Medical Command
U.S. Army Intelligence and Security Command
U.S. Army Corps of Engineers
(CONT)
3
SUBJECT: Army Directive 2025-11 (Administrative Absence for Non-covered Assisted
Reproductive Technology)
DISTRIBUTION: (CONT)
U.S. Army Military District of Washington
U.S. Army Test and Evaluation Command
U.S. Army Human Resources Command
U.S. Army Corrections Command
U.S. Army Recruiting Command
Superintendent, U.S. Military Academy
Commandant, U.S. Army War College
Director, U.S. Army Civilian Human Resources Agency
Executive Director, Military Postal Service Agency
Director, U.S. Army Criminal Investigation Division
Director, U.S. Army Joint Counter-Small Unmanned Aircraft Systems Office
Superintendent, Arlington National Cemetery
Director, U.S. Army Acquisition Support Center
CF:
Principal Cyber Advisor
Commander, Eighth Army
4
DEFINITIONS
eligible Soldier. For the purposes of this administrative absence guidance, active Soldiers,
including Reserve or National Guard Soldiers when on active-duty orders for 30 or more
consecutive days.
non-covered assisted reproductive technology (ART). Only the following components of
ART are included for purposes of authorized absences and official travel for non-covered
reproductive healthcare:
• ovarian stimulation and egg retrieval, including any needed medications and procedures
required for retrieval, processing, and utilization for ART or cryopreservation
• sperm collection and processing for ART or cryopreservation
• intrauterine insemination (IUI)
• in vitro fertilization (IVF), inclusive of these procedures for beneficiaries when clinically
indicated: IVF with fresh embryo transfer; gamete intrafallopian transfer (GIFT); zygote
intrafallopian transfer (ZIFT); pronuclear stage tubal transfer (PROST); tubal embryo
transfer (TET); and frozen embryo transfer
Enclosure